I
n the past decade, advancements in the technology of ultrasonography have led to the development of smaller ultrasonography devices and increased use of those devices at the point of care. Several studies in various clinical settings have shown incremental benefit when hand-carried ultrasonography is added to the general physical examination, and many investigators have suggested that these devices will someday become an integral part of the physical examination (1) (2) (3) (4) (5) .
Recently, the same advances in technology implemented for ultrasonography have been implemented for echocardiography. A pocket mobile echocardiography (PME) device that is roughly the size of a mobile phone and easily fits in a physician's pocket (weight, 13.8 oz; dimensions, 5.3 by 2.9 by 1.1 inches with a 3.8-MHz phased array transducer) was released directly to the medical community in February 2010 without documentation of its accuracy compared with standard transthoracic echocardiography (TTE). In this study, we compared the accuracy of PME as a quick assessment for clinical and subclinical cardiovascular disease with standard TTE by using blinded assessments from several cardiologists, and we calculated interobserver variability for PME image interpretation by experienced echocardiographers and by cardiology fellows with 2 months or less of training in echocardiographic interpretation.
METHODS

Sample
The institutional review board at Scripps Health approved this study. The study included a convenience sample of 97 inpatients and outpatients referred for TTE at the Scripps Clinic Torrey Pines and Scripps Green Hospital, La Jolla, California, from 22 February 2010 to 16 March 2010. The patients were selected according to a "next-available" model with even-numbered days dedicated primarily to inpatients and odd-numbered days dedicated primarily to outpatients, regardless of the indication for the imaging. We sought a roughly equal number of inpatients and outpatients to ensure variability of clinical presentation and indications for imaging (assuming more inpatients would have imaging for assessment of ischemia and more outpatients for murmurs). Clinicians ordering echocardiography were not aware that patients referred for TTE would also have PME.
Study Acquisition
Study ultrasonographers (n ϭ 14) attempted to acquire standard echocardiography projections of parasternal (long axis and short axis); subcostal; and apical 2-, 3-, and 4-chamber views with a PME (Vscan, GE Healthcare, Milwaukee, Wisconsin) (Figure 1 ) in 5 minutes or less immediately before doing comprehensive TTE with the Philips iE33 Echocardiograph System (Philips Medical Systems, Andover, Massachusetts). Ultrasonographers were encouraged to complete the PME examination in 5 minutes or less in an attempt to simulate the length of time that a physician might use the PME device as part of the physical examination in a clinical encounter. The Doppler flow function of the device was turned off to facilitate rapid acquisition of images in keeping with a first-pass screening examination.
Blinding
Every PME study was assigned a number, and patients were identifiable only by their medical record number. The ultrasonographers obtaining the images were not blinded to the clinical indication for the imaging study or the PME images when obtaining the standard TTE images. The physicians interpreting the PME images were blinded to the indication for the study and the results of the corresponding standard TTE but knew that the images they were interpreting came from a PME rather than a standard TTE device. Physician-readers interpreted standard TTE images in keeping with standard clinical care and were blinded to the results of the corresponding PME examination. Physicians interpreting the PME images had no involvement in the clinical care of patients.
Study Interpretation
Two cardiology fellows with 2 months or less of basic echocardiography training and 2 faculty cardiologists with advanced echocardiography training (level 3) in the 7 prespecified image elements (ejection fraction [normal or low], segmental wall-motion abnormality [yes or no], left The Vscan device is manufactured by GE Healthcare, Milwaukee, Wisconsin.
Context
A pocket mobile device is now commercially available for portable echocardiography.
Contribution
In this evaluation, the device produced images that were accurate for assessing ejection fraction and some but not all cardiac structures compared with standard echocardiography. Physicians with less experience disagreed more often about what the mobile images showed than did physicians with more experience.
Caution
The device was tested at a single center on a convenience sample of patients.
Implication
Pocket mobile echocardiography yields images that are accurate for assessing ejection fraction and some but not all cardiac structures. The findings are promising but suggest that the device is not ready for general use by clinicians who are untrained in obtaining and interpreting its images.
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Original enlarged]) individually interpreted PME images. Ejection fraction was considered low if it was less than 0.45 by visual estimation. Segmental wall motion was considered abnormal if there was at least 1 segment with lack of translational motion toward the centerline or lack of normal systolic thickening. Left ventricular end-diastolic dimension was measured in the parasternal long-axis view with electronic calipers built into the software of the PME device and was considered enlarged if greater than 5.3 cm for women or 5.9 cm for men. Pericardial effusion was considered clinically significant if it was at least moderate or associated with evidence of hemodynamic changes. The mitral valve was considered structurally abnormal if it seemed to have severe mitral annular calcification, prolapse, flail, or at least moderately thickened leaflets or subvalvular apparatus according to accepted criteria (6) . Aortic valve was considered stenotic if the valve was thickened or abnormally echodense and the leaflet opening seemed restricted in the representative views. Color flow and mitral regurgitation were not assessed for this study to facilitate rapid acquisition of images consistent with a first-pass screening examination. The inferior vena cava was considered dilated if its diameter was greater than 1.5 cm and there was less than 50% collapse during inspiration (corresponding to a right atrial pressure Ն10 mm Hg). Finally, each clinical element could also be classified as "not well-visualized" if the images were inadequate for interpretation. If a clinical element was not visualized with the standard TTE machine, the interpretation of that element on the corresponding PME was excluded from further analysis.
Statistical Analysis
The ability to visualize images (yes or no) is summarized as a proportion for each variable. To address the influence of body mass index (BMI) on the ability of PME to obtain images adequate for interpretation, the proportions of visualizable and nonvisualizable scans among patients with abnormal BMI (Ͻ18.5 or Ͼ30 kg/m 2 ) were compared by using the chi-square test. Estimates of accuracy of PME interpretations were calculated on the basis of proportion of accurate interpretations (sum of true-positive and true-negative readings) over the total number of scans visualized by both TTE and PME, with TTE serving as the gold standard. A more conservative estimate of accuracy was also calculated by using total scans as the denominator. The Cohen value was used to estimate agreement between 2 raters, and the Fleiss value was used to estimate agreement across all 4 raters (7). We estimated values by using interpretations of scans visualized by both or all of the raters being compared. Analyses were done with SAS software, version 9.2 (SAS Institute, Cary, North Carolina).
Role of the Funding Source
This work was funded by a Clinical and Translational Science Award from the National Institutes of Health to the Scripps Translational Science Institute. The funding source had no role in the study design, data collection or interpretation, writing of the report, or the decision to submit the manuscript for publication.
RESULTS
Baseline Characteristics
The characteristics of the 97 patients that we recruited are outlined in Table 1 . All standard TTE examinations were adequate for interpretation of ejection fraction, left ventricular end-diastolic dimension, aortic and mitral valves, and pericardial effusion. Only 1 standard TTE was not adequate for interpretation of wall-motion abnormality, and 2 of the examinations did not assess inferior vena cava size. Echocardiographic contrast (Definity, Lantheus Medical Imaging, North Billerica, Massachusetts) was required to assist interpretation of 8.2% of the standard TTE studies after the PME images had already been obtained.
Visualization
The proportion of PME images that were adequate for estimation of ejection fraction, left ventricular end-diastolic dimension, mitral valve and aortic valve pathology, wallmotion abnormality, and inferior vena cava size are summarized in Table 2 . There were no clinically significant 
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Pocket High-Resolution Echocardiography www.annals.orgpericardial effusions, but images were adequate for assessing effusions 94% of the time. Of the 6 cases of aortic stenosis read by the 2 attendings, the abnormality was identified on PME during 11 of 12 interpretations; the number of patients with nonvisualizable scans (for Ͼ1 of 4 readers) was largest for assessing inferior vena cava size (n ϭ 37) and wall-motion abnormality (n ϭ 34). Visualizability was generally greater in persons with normal BMI than in persons with abnormal BMI, but formal comparisons were not statistically significant (Appendix Table 1 , available at www.annals.org). Videos of the patients and echocardiographic images are available in the Supplement (available at www.annals.org).
PME Accuracy and Observer Variability
Accuracy of interpretation of PME images by attendings and fellows is detailed in Table 2 . Accuracy was highest when assessing ejection fraction and the aortic valve and lowest when assessing inferior vena cava size. When nonvisualizable scans were incorporated into the calculation of accuracy, it exceeded 90% only for ejection fraction. Rates of false-positive and false-negative readings differed by echocardiographic variable. False-positive readings ranged from 1% to 14% for attendings and 2% to 21% for fellows and were highest for inferior vena cava size (from 7% to 21% among readers), mitral valve pathology (6% to 21%), and wall-motion abnormality (5% to 13%). Rates of falsenegative readings ranged from 1% to 13% for attendings and 2% to 8% for fellows and were highest for inferior vena cava size (6% to 13%), left ventricular end-diastolic dimension (4% to 8%), and wall-motion abnormality (3% to 5%) (Appendix Table 2 , available at www.annals.org).
Observer agreement was fair to moderate for assessing mitral valve abnormalities and inferior vena cava size and more substantial for assessing left ventricular end-diastolic dimension, ejection fraction, wall-motion abnormality, and aortic valve abnormalities (8) . Observer variability was consistently higher for cardiology fellows ( ϭ 0.29 to 0.75) than for attendings ( ϭ 0.59 to 0.95). The largest discrepancy was for inferior vena cava size ( ϭ 0.39 for fellows; ϭ 0.84 for attendings) ( Table 2) . Figure 2 shows a stop-frame image of the aortic valve of a patient with critical aortic stenosis (A) and one with a normal aortic valve (B), as well as stop-frame images of a dilated (C) and a normal-sized (D) left ventricle.
Representative Images
DISCUSSION
We compared images acquired by PME and TTE and found that physician-readers who were blinded to TTE images could accurately visualize some but not all echocardiographic measurements on PME when images were obtained by the same ultrasonographer doing the TTE examination. Inferior vena cava imaging was suboptimal with PME compared with TTE interrogation, which may be due to protocol design. Sonographers had limited time to acquire images, and the inferior vena cava was the last structure to be imaged. Accuracy and between-physician agreement were higher for experienced cardiologists than for less-experienced cardiology fellows, and accuracy decreased when PME scans in which measurements could not be visualized were taken into account. Accuracy for this study was the total proportion of truepositive and true-negative readings; we did not formally calculate sensitivity and specificity because of the relatively small number of patients and few abnormal echocardiographic measurements.
The findings should be interpreted in the context that TTE had an advantage over PME because of the study design. We encouraged study ultrasonographers to complete the PME examination by assessing 7 prespecified measurements in 5 minutes or less to simulate a rapid screening examination during a clinical encounter. In a real-world clinical setting, the PME will probably be used IVC ϭ inferior vena cava; LVEDD ϭ left ventricular end-diastolic dimension; NA ϭ not available; TTE ϭ transthoracic echocardiography; WMA ϭ wall-motion abnormality. * TTE measurements were not visualized on every scan. The first estimate is the proportion of true-positive and true-negative readings among all scans in which the measurement was visualized (number varies by measurement). The second estimate is the proportion of true-positive and true-negative readings in all patients (n ϭ 97). † TTE comparison image missing for WMA assessment in 1 patient. ‡ TTE comparison image missing for IVC size assessment in 2 patients.
Original Research Pocket High-Resolution Echocardiography to do a more focused study directed by a specific clinical question, and 5 minutes seems to be a reasonable approximation of the time that such an examination might take. A recent group that used the same device demonstrated that a PME examination would be done in an average of 3 minutes (9). Additional ways in which the study design allowed standard TTE to have an advantage over PME is that we allowed use of echo contrast to better delineate endocardial borders in the TTE studies, and we disallowed use of PME color-flow capabilities, which might 
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Pocket High-Resolution Echocardiography have aided visualization and interpretation of images but would have been inconsistent with use of the device for first-pass screening and prolonged the time needed for the examination. We deemed it essential for this study to have the same ultrasonography technicians acquire all echocardiographic images (both PME and TTE) to maximize blinding and minimize confounding for the image-comparison analysis. However, ultrasonography technicians are unlikely to be the primary users of PME in clinical practice, and the results of our study that used skilled ultrasonographers cannot be generalized to untrained clinicians. Interpretation of PME images by less-experienced cardiology fellows in the study was slightly less accurate and more variable than that of cardiology attendings but might be expected to be more accurate and less variable than that of untrained noncardiology clinicians using the device. Although our limited experience suggests that a clinician with even minor experience in echocardiographic image acquisition (for example, a first-year cardiology fellow) can use the PME device to acquire quality images, a direct comparison of the accuracy of clinician-and ultrasonographer-acquired images, and of readings of those images by cardiologist and noncardiologist clinicians, would be desirable before the technology is disseminated for routine use by practicing clinicians.
The traditional stethoscope was invented by Laënnec in 1816, but for more than 20 years there were strong protests from the medical community about incorporating use of the instrument into the routine physical examination (10) because of physicians' unwillingness to learn heart sounds. Now, nearly 200 years later, PME provides an opportunity to quickly acquire noninvasive imaging of the major cardiac structures. The word stethoscope is derived from steth, the Greek word for "chest," and scope, which means "to look in." Clearly, the current "stethoscope" is actually a stethophone because it does not afford looking into the chest. Although standard transthoracic echocardiography, computed tomography, and magnetic resonance imaging offer a view inside the chest, their lack of portability, use of radiation, and the time required for such studies make them impractical substitutes for a pocket device that could be incorporated into the physical examination. Thus, it seems that PME may ultimately fulfill, with more extensive proof of accuracy, the actual concept of a pocket stethoscope.
The role of the PME device in contemporary U.S. health systems is unclear and requires economic considerations. The device currently costs $7900, and there is no reimbursement category for performing or interpreting PME. Rapid PME studies are free, in comparison with TTE, which is associated with a technical and professional fee exceeding $1500 and an average of 40 minutes of an ultrasonographer's time per study. The potential of the PME device to reduce the need for unnecessary TTE requires assessment in a large health system in which incentives are aligned between the hospital and professional staff. The value of PME is determined by the expense of the device, savings of standard TTE, and convenience to both the physician and the patient.
In summary, our relatively small study (using a convenience sample of patients) suggests that rapid use of PME by skilled ultrasonographers yields accurate assessments of ejection fraction and some but not all cardiac structures in many patients. Further testing of the accuracy of the device in much larger patient cohorts with diverse cardiac abnormalities and with untrained clinicians obtaining and interpreting images is required before wide dissemination of this technology can be recommended.
